Phase II results of tasisulam-sodium in previously treated patients with metastatic breast cancer.

114 Background: Tasisulam, a novel acylsulfonamide antineoplastic agent, promotes apoptosis, exhibits antiangiogenic activities, and demontrates antiproliferative activity against human breast canc...